B. Riley has increased its price target for Hyperfine, Inc. to $1.60 from $1.30. The firm reiterated its Buy rating on the medical imaging technology company's stock.
B. Riley Raises Hyperfine Price Target to $1.60, Maintains Buy Rating
HYPRAnalyst RatingsPrice TargetMedical TechnologyHealthcare Stocks



